KIA
CYTK icon

Kopp Investment Advisors’s Cytokinetics CYTK Stock Holding History

Kopp Investment Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,197
Closed -$97K – 72
2014
Q1 		$97K Sell
10,197
-16,804
-62% -$152K 0.04% 67
2013
Q4 		$176K Sell
27,001
-67,138
-71% -$441K 0.08% 61
2013
Q3 		$713K Sell
94,139
-13,204
-12% -$142K 0.26% 75
2013
Q2 		$1.24M Buy
+107,343
New +$846K 0.49% 42

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Kopp Investment Advisors's CYTK Position: Q2 2014 in Review

Kopp Investment Advisors sold out of Cytokinetics (CYTK) in Q2 2014, closing a stake of 10,197 shares — an estimated $97K sold.

Kopp Investment Advisors first reported a position in CYTK in Q2 2013 and held it in 4 quarters. The position peaked at $1.24M in Q2 2013. 89 funds tracked by Wall St. Rank hold CYTK as of Q2 2014.

  • Kopp Investment Advisors reported no remaining Cytokinetics position as of Q2 2014 after selling out during the quarter.
  • Kopp Investment Advisors sold 10,197 Cytokinetics shares in Q2 2014, an estimated $97K.
  • Kopp Investment Advisors first reported a position in Cytokinetics in Q2 2013 and held it in 4 quarters.
  • Kopp Investment Advisors's Cytokinetics position peaked at $1.24M in Q2 2013.
  • 89 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2014.

Based on Kopp Investment Advisors's 13F filing for Q2 2014, filed 1 Aug 2014.